BET protein inhibitor apabetalone (RVX-208) suppresses...

Clinical Epigenetics 2020 / 12 Vol. 12; Iss. 1

BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes

Wasiak, Sylwia, Dzobo, Kim E., Rakai, Brooke D., Kaiser, Yannick, Versloot, Miranda, Bahjat, Mahnoush, Stotz, Stephanie C., Fu, Li, Sweeney, Michael, Johansson, Jan O., Wong, Norman C. W., Stroes, Eri
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
12
Journal:
Clinical Epigenetics
DOI:
10.1186/s13148-020-00943-0
Date:
December, 2020
File:
PDF, 2.35 MB
2020
Conversion to is in progress
Conversion to is failed